Vanguard disaggregates holdings; reports 0 shares of Nu Skin (NYSE: NUS)
Rhea-AI Filing Summary
Nu Skin Enterprises Inc: The Vanguard Group reports it beneficially owns 0 shares (0%) of Nu Skin common stock following an internal realignment. The filing states certain Vanguard subsidiaries now report separately in reliance on SEC Release No. 34-39538 (January 12, 1998), and Vanguard no longer is deemed to beneficially own securities held by those subsidiaries. The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What caused The Vanguard Group to report zero ownership in NUS?
An internal realignment on January 12, 2026 led Vanguard to disaggregate subsidiaries’ holdings. The filing cites SEC Release No. 34-39538 (January 12, 1998) as the basis for separate reporting and loss of deemed beneficial ownership.
Who filed the Schedule 13G/A for Nu Skin (NUS)?
The Schedule 13G/A was filed by The Vanguard Group, with the reporting signature by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.
Does the filing list any subsidiary holdings or >5% holders for NUS?
No other person’s interest reported exceeds 5%. The filing states Vanguard’s investment companies and managed accounts have rights to dividends or proceeds, and no single outside interest exceeds five percent.
What SEC guidance does Vanguard cite for its reporting change in NUS?
The filing relies on SEC Release No. 34-39538 (January 12, 1998), explaining that certain subsidiaries now report beneficial ownership separately and Vanguard is no longer deemed to beneficially own those securities.